Literature DB >> 7979217

The retinoblastoma gene is involved in malignant progression of astrocytomas.

J W Henson1, B L Schnitker, K M Correa, A von Deimling, F Fassbender, H J Xu, W F Benedict, D W Yandell, D N Louis.   

Abstract

Loss of chromosome 13q occurs in up to 50% of human astrocytomas, suggesting the presence of an astrocytoma tumor suppressor gene on that chromosome. To determine whether the retinoblastoma susceptibility gene (Rb) on 13q14 contributes to the formation of astrocytomas, we examined 85 tumors for loss of heterozygosity (LOH) at the intragenic Rb 1.20 locus. LOH was detected in 16 of 54 informative high-grade astrocytomas (30%), but was not detected in 12 low-grade gliomas. Deletion mapping with flanking markers on 13q revealed that the Rb 1.20 region was preferentially targeted by the deletions. Tumors with LOH at Rb 1.20 were examined for mutations in the remaining Rb allele using single-strand conformational polymorphism (SSCP) analysis and direct DNA sequencing. Mutations were detected in exon 8 (1 tumor), exon 24 (2 tumors), and intron 24 (1 tumor). Rb protein expression, as assessed by immunohistochemistry, was altered in 3 of 9 cases with LOH and in 1 tumor without LOH. Our results demonstrate that Rb inactivation contributes to the formation of high-grade astrocytomas, and therefore implicate a second, known tumor suppressor gene in astrocytoma tumorigenesis.

Entities:  

Mesh:

Year:  1994        PMID: 7979217     DOI: 10.1002/ana.410360505

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  53 in total

1.  Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping.

Authors:  D Krex; B Mohr; M Hauses; G Ehninger; H K Schackert; G Schackert
Journal:  J Neurooncol       Date:  2001-04       Impact factor: 4.130

2.  Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma.

Authors:  A Rencic; J Gordon; J Otte; M Curtis; A Kovatich; P Zoltick; K Khalili; D Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Genomic alterations in human glioma cell lines detected by restriction landmark genomic scanning.

Authors:  M Nakamura; N Konishi; S Tsunoda; Y Hiasa; T Tsuzuki; K Takemura; K Kobitsu; T Sakaki
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

Review 4.  Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.

Authors:  Kimberly Ng; Ryan Kim; Santosh Kesari; Bob Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2011-10-16       Impact factor: 4.130

5.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

6.  Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique.

Authors:  H E Miettinen; N Paunu; I Rantala; H Kalimo; L Paljärvi; H Helin; H Haapasalo
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

7.  Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks.

Authors:  C Martins; M A Kedda; M C Kew
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

8.  Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.

Authors:  M T Jennings; C E Hart; P A Commers; J A Whitlock; D Martincic; R J Maciunas; P L Moots; T M Shehab
Journal:  J Neurooncol       Date:  1997-02       Impact factor: 4.130

9.  PCNA and Ki-67 labelling indices in pre-irradiated and post-irradiated astrocytomas: a comparative immunohistochemical analysis for evaluation of proliferative activity.

Authors:  E Pierce; R Doshi; R Deane
Journal:  Mol Pathol       Date:  1998-04

Review 10.  Techniques to assess the proliferative potential of brain tumors.

Authors:  Alfredo Quiñones-Hinojosa; Nader Sanai; Justin S Smith; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.